 Lauren Vanderlinden
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 9 | 2024 | 611 | 1.510 |
Why?
| | Alcohol Drinking | 6 | 2018 | 765 | 1.030 |
Why?
| | Islets of Langerhans | 7 | 2024 | 789 | 0.780 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2024 | 3628 | 0.660 |
Why?
| | Rats, Inbred Strains | 4 | 2019 | 368 | 0.660 |
Why?
| | Quantitative Trait Loci | 5 | 2020 | 353 | 0.650 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2022 | 247 | 0.640 |
Why?
| | Autoimmunity | 9 | 2024 | 863 | 0.570 |
Why?
| | Arthritis, Rheumatoid | 3 | 2024 | 1098 | 0.570 |
Why?
| | Quantitative Trait, Heritable | 2 | 2017 | 121 | 0.550 |
Why?
| | Genetic Predisposition to Disease | 8 | 2024 | 2274 | 0.540 |
Why?
| | Gene Regulatory Networks | 4 | 2019 | 281 | 0.520 |
Why?
| | Autoantibodies | 6 | 2024 | 1468 | 0.510 |
Why?
| | Genome-Wide Association Study | 6 | 2024 | 1326 | 0.510 |
Why?
| | Brain | 8 | 2022 | 2673 | 0.500 |
Why?
| | Darkness | 1 | 2015 | 25 | 0.470 |
Why?
| | Alcoholism | 3 | 2014 | 765 | 0.420 |
Why?
| | Oxylipins | 3 | 2023 | 33 | 0.400 |
Why?
| | Circadian Rhythm | 1 | 2015 | 413 | 0.360 |
Why?
| | Phenotype | 2 | 2015 | 3075 | 0.320 |
Why?
| | Systems Biology | 2 | 2019 | 60 | 0.290 |
Why?
| | Algorithms | 3 | 2024 | 1616 | 0.290 |
Why?
| | CpG Islands | 3 | 2023 | 152 | 0.280 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 226 | 0.260 |
Why?
| | Diet | 3 | 2021 | 1213 | 0.230 |
Why?
| | Male | 27 | 2024 | 63670 | 0.230 |
Why?
| | Metabolomics | 5 | 2021 | 653 | 0.230 |
Why?
| | Seroconversion | 2 | 2021 | 46 | 0.220 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 45 | 0.220 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1687 | 0.220 |
Why?
| | Mice, Inbred Strains | 2 | 2015 | 406 | 0.210 |
Why?
| | Ethanol | 2 | 2018 | 591 | 0.210 |
Why?
| | Extracellular Matrix | 2 | 2021 | 506 | 0.210 |
Why?
| | Rats | 9 | 2019 | 5483 | 0.200 |
Why?
| | Animals | 19 | 2022 | 35391 | 0.200 |
Why?
| | Adiposity | 2 | 2017 | 504 | 0.200 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1164 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 274 | 0.190 |
Why?
| | Humans | 36 | 2024 | 129625 | 0.190 |
Why?
| | Case-Control Studies | 7 | 2023 | 3378 | 0.190 |
Why?
| | Disease Progression | 3 | 2024 | 2627 | 0.190 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 64 | 0.180 |
Why?
| | Propensity Score | 1 | 2023 | 264 | 0.180 |
Why?
| | Lipid Metabolism | 3 | 2019 | 503 | 0.180 |
Why?
| | Risk Factors | 7 | 2023 | 9786 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 13 | 0.180 |
Why?
| | Vitamins | 1 | 2022 | 173 | 0.180 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 97 | 0.170 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 209 | 0.170 |
Why?
| | Child, Preschool | 10 | 2024 | 10490 | 0.170 |
Why?
| | Diseases in Twins | 1 | 2021 | 176 | 0.170 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 15 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 137 | 0.170 |
Why?
| | Female | 23 | 2024 | 68734 | 0.170 |
Why?
| | Receptors, Androgen | 1 | 2021 | 143 | 0.160 |
Why?
| | Epigenesis, Genetic | 5 | 2024 | 617 | 0.160 |
Why?
| | Phospholipids | 1 | 2021 | 216 | 0.160 |
Why?
| | Drosophila | 1 | 2020 | 141 | 0.160 |
Why?
| | Genotype | 2 | 2015 | 1833 | 0.160 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 756 | 0.160 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 209 | 0.160 |
Why?
| | Mice | 9 | 2022 | 16961 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 104 | 0.150 |
Why?
| | Child | 13 | 2024 | 20884 | 0.150 |
Why?
| | Eicosanoids | 1 | 2019 | 57 | 0.150 |
Why?
| | Fluorenes | 1 | 2019 | 40 | 0.150 |
Why?
| | Drosophila Proteins | 1 | 2020 | 185 | 0.150 |
Why?
| | Scoliosis | 1 | 2021 | 197 | 0.150 |
Why?
| | Vitamin D | 1 | 2022 | 381 | 0.150 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 255 | 0.150 |
Why?
| | Hippocampus | 2 | 2022 | 873 | 0.150 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 18 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 117 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 107 | 0.150 |
Why?
| | Body Mass Index | 2 | 2024 | 2274 | 0.150 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 40 | 0.140 |
Why?
| | Health Status | 1 | 2023 | 756 | 0.140 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2017 | 5 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2024 | 2060 | 0.140 |
Why?
| | Fatty Acids | 2 | 2017 | 427 | 0.140 |
Why?
| | Phthalic Acids | 1 | 2018 | 46 | 0.140 |
Why?
| | GABA Modulators | 1 | 2017 | 12 | 0.140 |
Why?
| | CD24 Antigen | 1 | 2017 | 20 | 0.140 |
Why?
| | Food Hypersensitivity | 1 | 2020 | 176 | 0.140 |
Why?
| | Prospective Studies | 4 | 2023 | 7135 | 0.140 |
Why?
| | Transcriptome | 3 | 2018 | 876 | 0.140 |
Why?
| | Genetic Association Studies | 2 | 2020 | 362 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2023 | 5075 | 0.130 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 150 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 319 | 0.130 |
Why?
| | Voltage-Gated Sodium Channels | 1 | 2016 | 5 | 0.130 |
Why?
| | Seizures | 1 | 2020 | 401 | 0.130 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 126 | 0.130 |
Why?
| | Maternal Exposure | 1 | 2018 | 177 | 0.130 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 191 | 0.130 |
Why?
| | Anxiety | 1 | 2022 | 972 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 88 | 0.120 |
Why?
| | Insulin | 3 | 2021 | 2326 | 0.120 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 16 | 0.120 |
Why?
| | Quinolines | 1 | 2016 | 156 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1336 | 0.120 |
Why?
| | Cohort Studies | 2 | 2022 | 5426 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2015 | 116 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 487 | 0.110 |
Why?
| | Neuralgia | 1 | 2016 | 126 | 0.110 |
Why?
| | Birth Weight | 1 | 2017 | 506 | 0.110 |
Why?
| | Infant | 7 | 2024 | 8995 | 0.110 |
Why?
| | Obesity | 2 | 2017 | 2882 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 190 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 211 | 0.110 |
Why?
| | Cell Nucleus | 1 | 2017 | 584 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2021 | 2373 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 939 | 0.110 |
Why?
| | Behavior, Addictive | 1 | 2014 | 81 | 0.110 |
Why?
| | Adolescent | 8 | 2024 | 20412 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 391 | 0.100 |
Why?
| | Species Specificity | 1 | 2014 | 574 | 0.100 |
Why?
| | Adenylyl Cyclases | 1 | 2012 | 83 | 0.100 |
Why?
| | Choice Behavior | 1 | 2014 | 168 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 824 | 0.100 |
Why?
| | Gene Expression | 1 | 2017 | 1465 | 0.100 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2012 | 80 | 0.100 |
Why?
| | Neurons | 2 | 2020 | 1494 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1056 | 0.100 |
Why?
| | Ibuprofen | 1 | 2012 | 81 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2442 | 0.090 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.090 |
Why?
| | Placenta | 1 | 2018 | 723 | 0.090 |
Why?
| | Sequence Analysis, RNA | 2 | 2024 | 427 | 0.090 |
Why?
| | Lipocalin 1 | 1 | 2011 | 2 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 4 | 2020 | 2395 | 0.090 |
Why?
| | Base Sequence | 1 | 2015 | 2147 | 0.090 |
Why?
| | Blastocyst | 1 | 2011 | 47 | 0.090 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2720 | 0.090 |
Why?
| | Culture Media | 1 | 2011 | 162 | 0.090 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 78 | 0.090 |
Why?
| | Models, Genetic | 1 | 2013 | 593 | 0.090 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 80 | 0.090 |
Why?
| | Aneuploidy | 1 | 2011 | 92 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 179 | 0.080 |
Why?
| | Pediatric Obesity | 1 | 2017 | 573 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2835 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1842 | 0.080 |
Why?
| | Postpartum Period | 1 | 2012 | 333 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 194 | 0.080 |
Why?
| | Depressive Disorder, Major | 1 | 2012 | 345 | 0.080 |
Why?
| | Sex Factors | 1 | 2015 | 1970 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 523 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1198 | 0.070 |
Why?
| | Mice, Nude | 2 | 2021 | 682 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 943 | 0.070 |
Why?
| | Rats, Inbred BN | 2 | 2018 | 59 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2014 | 2708 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 2225 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 808 | 0.060 |
Why?
| | Pregnancy | 4 | 2020 | 6417 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 4931 | 0.060 |
Why?
| | Proteomics | 1 | 2011 | 1055 | 0.060 |
Why?
| | Monte Carlo Method | 1 | 2024 | 143 | 0.060 |
Why?
| | Body Height | 1 | 2024 | 192 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 120 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 840 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 120 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2023 | 97 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2020 | 1891 | 0.050 |
Why?
| | Epitopes | 1 | 2023 | 472 | 0.050 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2021 | 4894 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 41 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 63 | 0.040 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2020 | 4 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 115 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 3774 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 82 | 0.040 |
Why?
| | Colorado | 2 | 2023 | 4404 | 0.040 |
Why?
| | Probability | 1 | 2021 | 306 | 0.040 |
Why?
| | Apoptosis | 2 | 2021 | 2492 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 34 | 0.040 |
Why?
| | Bias | 1 | 2021 | 197 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 940 | 0.040 |
Why?
| | Inflammation | 2 | 2024 | 2750 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 569 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 317 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 188 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 47 | 0.040 |
Why?
| | Precision Medicine | 1 | 2023 | 387 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 138 | 0.040 |
Why?
| | Chimera | 1 | 2019 | 60 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 580 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 329 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 502 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2020 | 140 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 18 | 0.040 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 44 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 176 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 233 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 241 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 276 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 129 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 423 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| | Radioligand Assay | 1 | 2017 | 48 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 435 | 0.040 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.030 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 137 | 0.030 |
Why?
| | Electron Transport | 1 | 2017 | 112 | 0.030 |
Why?
| | Xenopus laevis | 1 | 2017 | 98 | 0.030 |
Why?
| | Carnitine | 1 | 2017 | 76 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2019 | 813 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 83 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 378 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 90 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 973 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 103 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 419 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1212 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 805 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 233 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 24 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 320 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 168 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1250 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 5756 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 108 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 154 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 279 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 169 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 481 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 33 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1713 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 388 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 863 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 2015 | 190 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1248 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 442 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 487 | 0.030 |
Why?
| | Software | 1 | 2019 | 608 | 0.030 |
Why?
| | Lipids | 1 | 2017 | 627 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1028 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1282 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 698 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2784 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2739 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 3968 | 0.030 |
Why?
| | Basement Membrane | 1 | 2012 | 31 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1872 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 42 | 0.020 |
Why?
| | Laminin | 1 | 2012 | 69 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 482 | 0.020 |
Why?
| | Adult | 3 | 2021 | 35599 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1491 | 0.020 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 179 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2017 | 875 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 12455 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 876 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 144 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 731 | 0.020 |
Why?
| | RNA | 1 | 2017 | 882 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 11 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1266 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1125 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 475 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 574 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4078 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 327 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1720 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7052 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 423 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 834 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6555 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2542 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5415 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1947 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 4084 | 0.010 |
Why?
| | Aged | 1 | 2023 | 22061 | 0.010 |
Why?
|
|
Vanderlinden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|